Samuel David

2,9-Dioxa tricyclo [4,3,1,03,7 ] decane compounds and process of making same

2,9-Dioxatricyclo[4,3,1,03,7 ]decane derivatives, processes for their preparation and pharmaceutical compositions thereof

Process for preparing 10-methyl-2,9-dioxatricyclo[4,3,1,03,7 ] decanes

Novel valepotriate hydrin containing medicines

2,9-Dioxatricyclo[4,3,1,03,7]decane derivatives and pharmaceutical compositions thereof

2,6-Dioxa-bicyclo-[2,2,2]-octane-7-yl-acetaldehydes

Valepotriate hydrin containing medicines used to treat uclers and motility disturbances

N-(2,10-dioxa-tricyclo-[5,3,1,03,8]-undecane-5-yl)-tryptamine derivatives and medical compositions thereof

N-(2,10-dioxa-tricyclo û5,3,1,0 3,8¨ undecan-5-yl)-tryptamine derivatives

2,6-dioxa-bicyclo-û2,2,2¨-octan-7-yl-acetaldehydes